Total Payments
$754.47
2024 Payments
$56.16
Companies
12
Transactions
29
Medicare Patients
2,909
Medicare Billing
$396,091

Payment Breakdown by Category

Food & Beverage$754.47 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $754.47 29 100.0%

Top Paying Companies

Company Total Records Latest Year
Merck Sharp & Dohme Corporation $181.99 8 $0 (2018)
PFIZER INC. $153.66 4 $0 (2018)
E.R. Squibb & Sons, L.L.C. $121.33 1 $0 (2020)
Janssen Pharmaceuticals, Inc $113.65 4 $0 (2024)
Novartis Pharmaceuticals Corporation $44.48 3 $0 (2017)
Boston Scientific Corporation $29.07 2 $0 (2019)
Dendreon Pharmaceuticals LLC $27.87 1 $0 (2018)
Allergan Inc. $22.13 2 $0 (2019)
Boehringer Ingelheim Pharmaceuticals, Inc. $17.94 1 $0 (2017)
ZS Pharma. Inc. $16.74 1 $0 (2017)

Payment History by Year

Year Amount Transactions Top Company
2024 $56.16 2 Janssen Pharmaceuticals, Inc ($56.16)
2023 $24.87 1 Janssen Pharmaceuticals, Inc ($24.87)
2020 $153.95 2 E.R. Squibb & Sons, L.L.C. ($121.33)
2019 $27.03 2 Boston Scientific Corporation ($15.73)
2018 $312.88 9 Merck Sharp & Dohme Corporation ($139.92)
2017 $179.58 13 Novartis Pharmaceuticals Corporation ($44.48)

All Payment Transactions

29 individual payment records from CMS Open Payments — Page 1 of 2

Date Company Product Nature Form Amount Type
09/23/2024 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $21.37 General
Category: Cardiovascular & Metabolism
04/03/2024 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $34.79 General
Category: Cardiovascular & Metabolism
04/21/2023 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $24.87 General
Category: Cardiovascular & Metabolism
09/14/2020 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $32.62 General
Category: Cardiovascular & Metabolism
02/12/2020 E.R. Squibb & Sons, L.L.C. ELIQUIS (Drug) Food and Beverage Cash or cash equivalent $121.33 General
Category: Cardiovascular
04/11/2019 Allergan Inc. AVYCAZ (Drug) Food and Beverage In-kind items and services $11.30 General
Category: ANTI-INFECTIVE
04/03/2019 Boston Scientific Corporation WATCHMAN (Device) Food and Beverage In-kind items and services $15.73 General
Category: STRUCTURAL HEART
05/30/2018 Dendreon Pharmaceuticals LLC PROVENGE (Drug) Food and Beverage In-kind items and services $27.87 General
Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER
05/30/2018 BOSTON SCIENTIFIC CORPORATION WATCHMAN (Device) Food and Beverage In-kind items and services $13.34 General
Category: STRUCTURAL HEART
05/14/2018 Merck Sharp & Dohme Corporation DIFICID (Drug), ZINPLAVA Food and Beverage In-kind items and services $13.48 General
Category: INFECTIOUS DISEASE
05/08/2018 PFIZER INC. ELIQUIS (Drug) Food and Beverage In-kind items and services $120.22 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
04/17/2018 PFIZER INC. CHANTIX (Drug) Food and Beverage In-kind items and services $11.53 General
Category: NEUROSCIENCE;TOBACCO DEPENDENCE
04/16/2018 Merck Sharp & Dohme Corporation DIFICID (Drug), ZINPLAVA Food and Beverage In-kind items and services $94.39 General
Category: INFECTIOUS DISEASE
03/22/2018 Merck Sharp & Dohme Corporation ZERBAXA (Drug), SIVEXTRO Food and Beverage In-kind items and services $12.68 General
Category: INFECTIOUS DISEASE
02/14/2018 Merck Sharp & Dohme Corporation ZERBAXA (Drug), SIVEXTRO Food and Beverage In-kind items and services $9.62 General
Category: INFECTIOUS DISEASE
01/25/2018 Merck Sharp & Dohme Corporation DIFICID (Drug), ZINPLAVA Food and Beverage In-kind items and services $9.75 General
Category: INFECTIOUS DISEASE
10/30/2017 Mannkind Corporation AFREZZA (Drug) Food and Beverage In-kind items and services $14.78 General
Category: DIABETES MEDICINE
10/25/2017 PFIZER INC. ELIQUIS (Drug) Food and Beverage In-kind items and services $10.41 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
08/24/2017 Novartis Pharmaceuticals Corporation ENTRESTO (Drug) Food and Beverage In-kind items and services $16.26 General
Category: CARDIOVASCULAR
07/24/2017 PFIZER INC. ELIQUIS (Drug) Food and Beverage In-kind items and services $11.50 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
07/20/2017 Merck Sharp & Dohme Corporation DIFICID (Drug) Food and Beverage In-kind items and services $12.52 General
Category: INFECTIOUS DISEASE
05/31/2017 Novartis Pharmaceuticals Corporation ENTRESTO (Drug) Food and Beverage In-kind items and services $15.64 General
Category: CARDIOVASCULAR
05/04/2017 ZS Pharma. Inc. BRILINTA (Drug) Food and Beverage In-kind items and services $16.74 General
Category: Cardiovascular and Metabolism
05/02/2017 Merck Sharp & Dohme Corporation DIFICID (Drug) Food and Beverage In-kind items and services $13.85 General
Category: INFECTIOUS DISEASE
04/11/2017 Novartis Pharmaceuticals Corporation ENTRESTO (Drug) Food and Beverage In-kind items and services $12.58 General
Category: CARDIOVASCULAR

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 5 599 1,018 $352,111 $86,207
2022 7 687 1,066 $384,232 $94,536
2021 8 778 1,209 $463,493 $108,685
2020 12 845 1,251 $877,869 $106,663
Total Patients
2,909
Total Services
4,544
Medicare Billing
$396,091
Procedure Codes
32

All Medicare Procedures & Services

32 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 234 576 $153,264 $38,817 25.3%
99239 Hospital discharge day management, more than 30 minutes Facility 2023 189 197 $77,287 $19,204 24.8%
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 83 151 $57,324 $15,238 26.6%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 82 83 $61,310 $12,188 19.9%
99238 Hospital discharge day management, 30 minutes or less Facility 2023 11 11 $2,926 $759.55 26.0%
99233 Follow-up hospital inpatient care per day, typically 35 minutes Facility 2022 233 484 $174,886 $43,050 24.6%
99239 Hospital discharge day management, more than 30 minutes Facility 2022 183 196 $73,045 $18,143 24.8%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 125 239 $60,436 $14,969 24.8%
99223 Initial hospital inpatient care per day, typically 70 minutes Facility 2022 65 65 $45,705 $11,081 24.2%
99220 Initial hospital observation care per day, typically 70 minutes Facility 2022 20 20 $12,784 $3,088 24.2%
99217 Hospital observation care on day of discharge Facility 2022 47 47 $11,943 $2,912 24.4%
99226 Follow-up observation care per day, typically 35 minutes Facility 2022 14 15 $5,433 $1,293 23.8%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2021 257 544 $214,113 $48,852 22.8%
99239 Hospital discharge day management, more than 30 minutes Facility 2021 222 234 $92,266 $21,803 23.6%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2021 134 264 $68,796 $16,555 24.1%
99223 Initial hospital inpatient care, typically 70 minutes per day Facility 2021 83 85 $60,589 $14,725 24.3%
99217 Hospital observation care on day of discharge Facility 2021 39 39 $9,676 $2,438 25.2%
99220 Hospital observation care, typically 70 minutes Facility 2021 13 13 $9,364 $2,043 21.8%
99221 Initial hospital inpatient care, typically 30 minutes per day Facility 2021 15 15 $5,025 $1,307 26.0%
99238 Hospital discharge day management, 30 minutes or less Facility 2021 15 15 $3,665 $962.28 26.3%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2020 213 366 $271,243 $33,293 12.3%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2020 200 407 $208,583 $25,178 12.1%
99239 Hospital discharge day management, more than 30 minutes Facility 2020 184 195 $148,923 $18,107 12.2%
99223 Initial hospital inpatient care, typically 70 minutes per day Facility 2020 77 79 $113,721 $13,895 12.2%
99220 Hospital observation care, typically 70 minutes Facility 2020 41 41 $54,075 $6,469 12.0%

About Dr. Jason Son, DO

Dr. Jason Son, DO is a Student in an Organized Health Care Education/Training Program healthcare provider based in Framingham, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/11/2015. The National Provider Identifier (NPI) number assigned to this provider is 1508252065.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jason Son, DO has received a total of $754.47 in payments from pharmaceutical and medical device companies, with $56.16 received in 2024. These payments were reported across 29 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($754.47).

As a Medicare-enrolled provider, Son has provided services to 2,909 Medicare beneficiaries, totaling 4,544 services with total Medicare billing of $396,091. Data is available for 4 years (2020–2023), covering 32 distinct procedure/service records.

Practice Information

Products in Payments

  • ELIQUIS (Drug) $263.46
  • DIFICID (Drug) $143.99
  • XARELTO (Drug) $113.65
  • ENTRESTO (Drug) $44.48
  • WATCHMAN (Device) $29.07
  • PROVENGE (Drug) $27.87
  • ZERBAXA (Drug) $22.30
  • JARDIANCE (Drug) $17.94
  • BRILINTA (Drug) $16.74
  • JANUVIA (Drug) $15.70
  • AFREZZA (Drug) $14.78
  • CHANTIX (Drug) $11.53
  • AVYCAZ (Drug) $11.30
  • ANORO (Drug) $10.83
  • DALVANCE (Drug) $10.83

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Student in an Organized Health Care Education/Training Program Doctors in Framingham